Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,721 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NKG7 Is a T-cell-Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy.
Wen T, Barham W, Li Y, Zhang H, Gicobi JK, Hirdler JB, Liu X, Ham H, Peterson Martinez KE, Lucien F, Lavoie RR, Li H, Correia C, Monie DD, An Z, Harrington SM, Wu X, Guo R, Dronca RS, Mansfield AS, Yan Y, Markovic SN, Park SS, Sun J, Qin H, Liu MC, Vasmatzis G, Billadeau DD, Dong H. Wen T, et al. Among authors: qin h. Cancer Immunol Res. 2022 Feb;10(2):162-181. doi: 10.1158/2326-6066.CIR-21-0539. Epub 2021 Dec 15. Cancer Immunol Res. 2022. PMID: 34911739 Free PMC article.
Solid cancer-directed CAR T cell therapy that attacks both tumor and immunosuppressive cells via targeting PD-L1.
Luo Y, Gadd ME, Qie Y, Otamendi-Lopez A, Sanchez-Garavito JE, Brooks MM, Ulloa Navas MJ, Hundal T, Li S, Jones VK, Lou Y, Patel T, Dronca R, Kharfan-Dabaja MA, Dong H, Quinones-Hinojosa A, Qin H. Luo Y, et al. Among authors: qin h. Mol Ther Oncol. 2024 Oct 5;32(4):200891. doi: 10.1016/j.omton.2024.200891. eCollection 2024 Dec 19. Mol Ther Oncol. 2024. PMID: 39498357 Free PMC article.
Prospect of CAR T-cell therapy in acute myeloid leukemia.
Badar T, Manna A, Gadd ME, Kharfan-Dabaja MA, Qin H. Badar T, et al. Among authors: qin h. Expert Opin Investig Drugs. 2022 Feb;31(2):211-220. doi: 10.1080/13543784.2022.2032642. Epub 2022 Jan 24. Expert Opin Investig Drugs. 2022. PMID: 35051347
Driving Out Chronic Lymphocytic Leukemia With CAR T Cells.
Kharfan-Dabaja MA, Yassine F, Gadd ME, Qin H. Kharfan-Dabaja MA, et al. Among authors: qin h. Transplant Cell Ther. 2022 Jan;28(1):5-17. doi: 10.1016/j.jtct.2021.10.005. Epub 2021 Oct 14. Transplant Cell Ther. 2022. PMID: 34656807 Free article. Review.
Survival of Black and White Patients With Stage IV Small Cell Lung Cancer.
Shi H, Zhou K, Cochuyt J, Hodge D, Qin H, Manochakian R, Zhao Y, Ailawadhi S, Adjei AA, Lou Y. Shi H, et al. Among authors: qin h. Front Oncol. 2021 Dec 10;11:773958. doi: 10.3389/fonc.2021.773958. eCollection 2021. Front Oncol. 2021. PMID: 34956892 Free PMC article.
CAR T-cell therapy-paving the way for sensitized kidney transplant patients.
Jarmi T, Luo Y, Attieh RM, Qie Y, Gadd ME, Hundal T, Mao S, Murthy HS, Taner BC, Kharfan-Dabaja MA, Qin H. Jarmi T, et al. Among authors: qin h. Kidney Int. 2024 May;105(5):1124-1129. doi: 10.1016/j.kint.2024.02.008. Epub 2024 Apr 2. Kidney Int. 2024. PMID: 38573274 No abstract available.
Genomic landscape of lung adenocarcinomas in different races.
Shi H, Seegobin K, Heng F, Zhou K, Chen R, Qin H, Manochakian R, Zhao Y, Lou Y. Shi H, et al. Among authors: qin h. Front Oncol. 2022 Sep 28;12:946625. doi: 10.3389/fonc.2022.946625. eCollection 2022. Front Oncol. 2022. PMID: 36248982 Free PMC article.
5,721 results